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1INTRODUCTION
The amniotic membrane is a firm, tenacious membrane which acts as
a barrier between the fetus and the mother. It prevents the fetus from the
external environment which is harmful both to the fetus and the mother. The
amniotic fluid contains bactericidal agents, which  prevents the fetus from
being exposed to the harmful external environment. It acts as a cushion to
the fetus and prevents cord compression. It contains various inflammatory
mediators. Premature rupture of membrane due to any cause results in fetus
being exposed to infection resulting in chorioamnionitis. Also reduction in
fluid volume results in fetal heart rate changes. So for all these reasons,
premature rupture of membrane at term or before has to be managed either
by inducing labour or by caesarean section depending upon the period of
gestation, associated medical condition of the mother, estimated fetal
weight, cephalo pelvic disproportion if any.
AMNIOTIC FLUID
The source of amniotic fluid is both maternal and fetal.The amount of
fluid is related to the period of gestation. It measures about 50 ml at 12
weeks, 400 ml at 20 weeks and at 36 to 38 weeks, it reaches its peak about
1 liter and it’s level gradually decreases. At term, amniotic fluid measures
around 600-800ml. After 42 weeks of gestation, amniotic fluid volume
drastically decreases to about 200 ml and the fetus is said to be post mature.
2Amniotic fluid is faintly alkaline with low specific gravity of
1.01. An osmolarity of 250 mOsmol/L is suggestive of fetal maturity.
The osmolarity gradually falls with increasing gestation. In early
gestation it is colourless, but towards term, it becomes pale straw due
to the presence of exfoliated lanugo and epidermal cells from fetal
cells. In the first half of pregnancy, the fluid is identical to the transudate of
plasma. But in late pregnancy, the composition of amniotic fluid is a mainly
composed of the urinary metabolites.
3It functions as a shock absorber, protecting the fetus from possible
extraneous injury. It maintains an even temperature and allows free
movement of the foetus. During labour,adequate amount of liquor is
necessary for descent of fetus. The amnion and chorion form a hydrostatic
wedge which helps in dilatation of cervix. During uterine contractions, it
prevents marked interference with the placental circulation so long as the
membranes remain intact. It guards against umbilical cord compression.
The chorioamniotic membrane  acts as a barrier for the pathogens present in
the vagina.
DEFINITION
1. Premature rupture of the membrane (PROM) is defined as the
spontaneous rupture of the membranes after  28 weeks of gestation
but before the onset of uterine contraction.
2. Rupture of the membrane for more than 24 hours is called as
prolonged rupture of membrane.
3. Rupture of membrane before 37 weeks of gestation  is called as
preterm PROM
4. The incidence of PROM  is 7-18% at term. The infection is
closely associated to either an aetiological factor or an important
sequence of PROM.
PROM is usually confused with
4- Hydrorrhoea gravidarum ,a condition in which there is periodic
watery discharge which occurs due to excessive decidual
glandular secretion.
- Incontinence of urine which is most commonly seen in the later
trimester.
MANAGEMENT OF PROM
Management of PROM at term remains an enigma. Management of
spontaneous PROM is based on individualized approach. The different
modes of management are either expectant management or induction of
labour. The standard protocol for treating a patient with PROM at 37 weeks
or more is  to induce labour within 6-12 hours after the rupture of
membranes if the patient is not in labour. The rationale for this approach
to induce labour within 6 hours is to prevent the dreadful complication of
chorioamnionitis which is associated with high maternal & perinatal
morbidity and mortality.
Newborn born after 37 weeks of gestation has increased
chances of sepsis.
Newborn born before 37 weeks of gestation have the additional risk
of preterm which includes Respiratory distress syndrome ,necrotising
enterocolitis, intraventricular hemorrhage and increased need for neonatal
5resuscitation at delivery. So for all these reasons, induction of labour in
PROM has an advantage compared to expectant management.
Here is a study done at Tirunelveli medical college where I have
compared the safety and efficacy of the prostaglandin E2 gel administered
in endocervical canal with that of intravenous syntocinon infusion for
induction of labour in PROM.
6AIM OF THE STUDY
1. To compare the efficacy and safety of Prostaglandin E2 gel with
intravenous oxytocin for induction of labour in prelabour rupture of the
membrane.
2. To compare the PROM to induction interval between the two groups.
3. To compare the induction to delivery interval between the two groups.
4. To compare the mode of delivery between the two groups.
5. To compare the neonatal outcomes  b e tween  t h e  two  g r oup s .
6. To compare the immediate puerperal problems between the two groups.
7REVIEWOF LITERATURE
1. “A study was conducted by Goeshchen K et al in Department of O.G.
Germany,   in   term PROM   patients   for induction of   labour   with
endocervical ceviprime gel 0.5mg vs. intravenous oxytocin infusion.
The clinical outcome of labour, interval between the PROM to delivery,
the incidence of operative delivery and neonatal outcome, were
compared. 579 women in this study group were divided into two groups.
The  clinical outcome was  significantly  better  in  the PGE2  treated
patients.” There was no adverse effect noted in the neonate.
2. “A study conducted by Mahmood TA, in Department of OG, UK which
compared the conservative line of management vs. intravaginal PGE2
gel in term PROM cases and studied the main outcome of PROM  to
delivery, oxytocin augmentation, mode of delivery, maternal and
neonatal infective morbidity. There was a significant reduction in the
PROM to delivery interval in women who were managed actively with
PGE2 gel and fewer women required oxytocin augmentation. (31% Vs
51%).” The infective morbidity rate and caesarean section rate were
comparable in both the groups. There was no statistical significance
between the two groups.
83. “A study conducted by Tan BP, Hannah ME, compared
prostaglandin E2 gel vs. oxytocin for PROM cases at term. Early
stimulation of uterine contraction with prostaglandin with or without
oxytocin vs. oxytocin alone was made.   Eight trials were included.
Based on three trials, prostaglandin compared to oxytocin were
associated with increased risk of chorioamnionitis and neonatal infection.
Based on four trials, prostaglandins were associated with decreased need
for epidural analgesia”. No significant differences were made out
comparing the rate of endometritis, rate of operative morbidity and
hospital stay.
4. “In Meikel et al study  was conducted in Department of O&G, Denvar,
in patients with term PROM, the rate of endometritis, clinical
chorioamnionitis, caesarean delivery,  neonatal sepsis were analysed.
The caesarean setion rate was 12% and  Chorioamnionitis was observed
in 6.8%. Neonatal complications were limited to only 2 cases induced
with prostaglandin PGE2. The neonatal sepsis occurred in patients with
rupture of membranes for more than 24 hours managed expectantly”.
They have concluded that induction of labour with PGE2 gel resulted in
more vaginal delivery and less complications of chorioamnionitis.
95. “The  study  conducted  in the Department of OG, Ramalakanodi
hospital, Thailand, by Vennila et al, compared intravenous oxytocin
with or without 3mg  intravaginal PGE2 in term PROM cases regarding
the risk of chorioamnionitis.” There was no significant difference
between the two groups  regarding  induction to delivery interval and
puerperal complications.
6. “Arulkumaran et al, conducted a randomized comparision of vaginal
prostaglandin gel vs oxytocin infusion for stimulation of labour at term
for PROM.” This trial showed decreased requirement of epidural
analgesia and an increased incidence of chorioammionitis and related
puerperal complications with vaginal prostaglandin gel PGE2 (Tan &
Hannah 2000).   The perinatal morbidity rates and C- section rate were
similar. In  a women  with  term PROM, both PGE2 gel and oxytocin
were equally effective for induction of labour.
7. “A study conducted in Department of OG in NRS college, Kolkata by
Chaudhuri Snahamay et al, which compared the immediate induction
with  0.5mg  intravaginal  PGE2  gel and delayed induction with
intravenous oxytocin in term PROM cases”. The mode of delivery,
induction to delivery interval, neonatal  and maternal morbidity were
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comparable to both groups. 89% o f  p a t i e n t s required single
application of gel and early induction with intravaginal PGE2 gel
resulted in significantly lower caesarean section rate, (13.8% Vs 29.5%),
low operative vaginal delivery (3.9 Vs 13.2%) in primi compared to
oxytocin. There was no significant  difference seen in multipara.   No
significant differences were made out comparing the neonatal
infection rate in both groups. (2.8 Vs 4.5%).
8. “A study conducted by Shanman et al, which compared oxytocin with
PGE2 gel in cases of PROM with unripe cervix”. Cervical priming and
induction of labour in 24 primi term pregnant women with premature
rupture of membranes and unfavourable cervical state was done with
intravenous oxytocin for 12 cases and PGE2 gel 4 mg intravaginally
for 12 cases. One of the ten women who received oxytocin had a
favourable cervix within 5 hours and vaginal delivery within 24 hours
compared to six of the ten women after PGE2 gel application, which was
statistically significant. Number of caesarean section was 4 and vaccum
delivery was 5 in oxytocin group compared to only 2 vaccum deliveries
in cerviprime gel group”. According to this study, induction with gel has
resulted in less operative delivery, less hospital stay and less puerperal
complications compared to the oxytocin group.
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Incidence:
Varies from 2.7 to 17% (Lebherz et al 1969, Akthar et al 1980,
Singh et al 1990, Sanjal et al 1990). The reported incidence is varied greatly,
likely reflecting population demographics, the study   type, the study
interval, the method of diagnosis, the latency interval and the gestational age
at which PROM is diagnosed.
Etiology and pathogenesis:
1. The chorioamniotic membranes have dynamic properties
characteristic of a viscoelastic material. It has the ability to adapt to
deformation with recovery due to elastin. Membranes are stressed by
internal pressure due to labour, external pressure by trauma or
infection which weaken & increase the susceptibility to premature
rupture of membranes (Toppozada et al)
2. Infection: It is the major etiologic agent in the pathogenesis of
PROM . The organisms responsible are:
1.Group B streptococcus
2.Bacteroids
3.Gardnerella vaginalis
4. Chlamydia
5. Gonorrhoea
The possible mechanisms are :
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a) Activation of phospholipase A2 enzyme & subsequent increase in
prostaglandin production which increases the uterine activity & adds
stress on the membranes (Bejan et al 1981.)
b) Infection   leads   to   production   of   proteolytic   enzymes   & liberation
of hydrogen peroxide which results in break down of membranes (Sharra
et al 1985).
c) Increase in the lysolecithin due to phospholipase A2 lowers the
membrane burst pressure.
3. A local defect at or near the cervix with reduction in type 3
collagen predisposes to membrane rupture.
4. Obstetric factors like multiple gestation & hydramnios
predispose to membrane rupture.
5. Sexual activity predisposes to PROM due to bacterial deposition
close to the cervical os. Stimulation of uterine activity by
orgasm or seminal prostaglandins could lead to PROM.
(Rayburn & Wilson 1980).
6. Low serum levels of ascorbic acid, copper, zinc have been
associated with PROM. A strong association between smoking &
PROM has been observed (Meyer et al 1977, Naeye et al 1982.)
7. Invasive procedures like amniocentesis, chorionic villi
sampling , fetoscopy, cordocentesis may result in PROM.
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8. Genetic disorders like Ehlers –Danlos syndrome.marfan syndrome
and other c o n n e c t i v e tissue disorders are associated with fragile
membrane
9. Increase in Prolactin level which changes the elastic property of fetal
membranes via its effect on the membrane water & electrolyte content
predisposes to PROM ( Ron et al).
Pathology:
There is thinning of the epithelium at the site of rupture with decrease
in tensile  strength.  Collagen  sheets  &  fibril  bundles  are dissolved &
replaced by amorphous material signifying disorientation of extracellular
matrix. Any factor which increases the mechanical stress on that area
certainly predisposes to early rupture.
Significance :
Rupture of membranes is of significance for three reasons.
1. If presenting part is not fixed in the pelvis the possibility of cord
prolapse & cord compression is increased.
2. Labour may occur shortly.
3. If labour is delayed for >24 hours there is increased likelihood of
serious maternal and neonatal infection.
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DIAGNOSIS:
Tools reported useful in diagnosis of PROM
History & examination Sonography & dye instillation
History Sonography
Observation of leak Evans blue
Fundal height Sodium fluorescin
Odour Methylene blue
Indigo carmine
Pyridium
Properties of amniotic fluid Microscopy/ Cytologystains
Ferning Lanugo
pH litmus Sudan 111
Bromothymol blue Masson trichome
Nitrazine Acridine orange
Papanicolaou
Diamine oxidase Nile blue sulphate
Vernix identification
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1. Observation of aminorrhexis:
Diagnosis is made easily when amniotic fluid is in posterior fornix.If
no fluid is present, slight pressure on the uterus and gentle movement of
the foetus may provoke leaking. Otherwise ask the patient to cough or strain.
Fluid should be collected over the lower blade of speculum before it comes
in contact with the vaginal wall.
2. Nitrazine Test:
The vaginal pH is normally 4.5-5.5. Amniotic fluid usually has a pH
of 7-7.5. Nitrazine paper quickly will turn to deep blue if the vaginal fluid
has an alkaline pH. The membranes probably are intact if the colour of
the paper   remains yellow   or   changes   to   olive-yellow.   Antiseptic
solutions, urine, blood & vaginal infections alter the vaginal pH and
cause  false  positive  results.  The  nitrazine  test produces  12.7  %  false
negative & 16.2% false positive results.
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3. Ferning:
Ferning results from drying out of salts in the amniotic fluid. It is
performed by placing the swab in the posterior fornix of the vagina to obtain
vaginal fluid. The sample is placed on a glass slide & allowed to dry, then
observed under the microscope looking for a crystallization pattern that
resembles a fern. Ferning is due to the presence of Nacl. False negative
ferning is due to blood or meconium (4.8%).
Figure: ARBORIZING PATTERN
4.Evaporation Test:
For the evaporation test, the endocervical sample is heated until the
water content has evaporated. If a white residue is left, amniotic fluid is
present. If the residue is brown the membranes are intact.
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5.Intraamniotic fluorescein:
1ml of a sterile solution of 5% sodium fluorescein is injected in to
the amniotic cavity. A tampon is placed in the vagina and examined with
long wave ultraviolet light 1 or 2 hr later. The detection of fluorescent
material is equivalent to a positive diagnosis of PROM. 1 ml of sterile
indigocarmine  may be used instead of fluorescein and the tampon is
inspected for the presence of blue discoloration.
6.Amnioscopy:
Amnioscopy  is  an  invasive  procedure  rarely  indicated  in  the
diagnosis / management of PROM. It requires a distensible cervix to
introduce a metallic or plastic cone for direct visualization of the membrane
and the amniotic fluid. Amnioscopymay cause PROM is patients with intact
membrane and may carry a large bacterial inoculum in to the amniotic
cavity in patients with PROM.
7.Sonography:
Presence of amniotic fluid rules out PROM. Amniotic fluid is
measured by four quadrant technique. False positive results can occur in
oligohydramnios. Occult loss may be missed as the reduction of amniotic
fluid is less. But sonography is not used primarily for diagnosing PROM.
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Intramniotic instillation of dye is an invasive procedure which is hardly used
due to the deleterious effect of dye, infection and missing of meconium
stained liquor.
8.Fetal fibronectin:
Fetal fibronectin is a large molecular weight glycoprotein present in
large amounts in the amniotic fluid.This test is done after 18 weeks of
gestation. This substance can be detected in the endocervix or vagina of
patients with PROM by means of ELISA. The test seems to the highly
accurate and is not affected by blood. But meconium may interfere.
9.Alpha fetoprotein test
AFP is present in high concentration at the amniotic fluid, but does
not exist in the vaginal secretion or in the urine. Therefore demonstration of
this substance in the vaginal secretion is an accurate test for diagnosis of
PROM. A study using a rapid calorimetric monoclonal antibody AFP test
found a sensitivity of 98% for AFP ,77% for Nitrazine, and 62% for ferning
. Specificity was 100% for AFP test. The test may be unreliable at term
because amniotic fluid AFP  decreases with  gestational age. Maternal
blood contamination affects the accuracy of the test.
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10.Diamine oxidase Test:
It  is  an  enzyme  produced  by  decidua, which  diffuses  into the
amniotic fluid. Measurement by a paper strips placed in vagina is an accurate
way to diagnose PROM.
11.Microscopic & cytological stains have limited role.
12.History, nitrazine test, ferning or nile blue staining are usually used
to evaluate the presence of membrane rupture. Positive results of any two
tests gives an accuracy of about 93%. Nile blue test is performed by
collecting fluid from the vaginal pull,centrifuged and stained with 0.1 %
Nile blue sulphate.Presence of orangish- blue cells indicate the presence of
fetal fat of sebaceous glands.
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COMPLICATIONS
Maternal complications:
1. Chorioamnionitis
Incidence is 9%.It depends on the gestational age of PROM, duration
of latent  period and amniotic fluid volume. Chorioamnionitis is
defined by one of the following signs:
1.Fever (two temperature elevations of > than
37.5oC occurring at least 1 hour apart or One temperature elevation of
> than 38oC)
2. Uterine tenderness
3. Foetal tachycardia (180/min)
4. WBC count >20000 /cu.mm
5. Foul smelling amniotic fluid
2. Postpartum endometritis
It is defined by any one of the following:
1. Fever after delivery (2 temperature elevations >38C
occurring at least 6 hours apart not including the first 24 hours)
2.Uterine tenderness
3.WBC count > 20,000 / cu.mm
4. Unhealthy lochia
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3.Abruptio placenta:
Incidence is 6%. It is due to progressive decrease in the intrauterine
surface area causing detachment.
4.Chances of caesarean rates are higher
Depends on the gestational age at which PROM occurs
1. Neonatal sepsis: Incidence increases to 1.4% due to PROM.
2. All complications of prematurity in preterm PROM  like
hypoglycemia,hypocalcemia,necrotizing enterocolitis,respiratory
distress syndrome,electrolyte imbalance,etc
3. Lung hypoplasia
4. Foetal deformities
5. During labour chances of cord prolapse and foetal distress is more
22
MANAGEMENT
After confirming PROM and gestational age, patients who require
immediate delivery should be identified. They are:
1. In Labour
2. At Term
3. With foetal distress
4. With congenital anamolies
5. Chorioamnionitis
6. Those who are at high risk for infection like diabetes, heart
disease, on immunosuppresants, sickle cell disease.
Management of patients at term or near term
This is controversial, expectant vs. active management. At term 90%
of patients will go into spontaneous labour at the end of 24hrs. 38% of
patients were not in labour even at the end of 24hrs which increases
likelihood of infection to 10%. Studies have shown that active
management is cost effective & gives better patient satisfaction.
According to ACOG practice guidelines June 1998 (Level A)
Patients who come with term PROM, labour may be induced at the time
of presentation or may be observed for 24-72 hours for onset of
spontaneous labour. Digital examination should not be performed in whom
immediate induction is not planned.
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Management of patients with gestational age<32 weeks
Management of these patients is a compromise between maternal
infection & pre maturity of the fetus. Expectant management is the mode
of treatment.
(According to ACOG practice bulletin (June 1998)
Antibiotics improve the perinatal outcome by reducing the chances
of infection. Antenatal steroids are to be administered to reduce the risk of
RDS, intra ventricular haemorrhage, necrotising entercolitis, neonatal death.
Tocolysis can be given to permit administration of steroids and antibiotics.
Digital examination should not be done. Terminate the pregnancy if there
are signs of chorioamnionitis.
Management of PROM in gestational age <26 weeks
This group of patients have a very poor perinatal outcome. 48%
will deliver within 3 days, 67% with in 1 week, 83% with in 2 weeks.
Perinatal mortality is 60-90%. 50% will develop chorioamniotitis, 6.8%will
have an abruption & 50% will be delivered by cesarean section. 16% of the
surviving newborns will have long term sequelae. If the latency is > 4
weeks there is high risk for fetal musculoskeletal  deformities &
pulmonary hypoplasia. No plan of management has shown to improve the
neonatal outcome.
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INDUCTION OF LABOR
Induction of labour means artificial stimulation of uterine contractions
before the onset of spontaneous labour  with the purpose of accomplishing
successful vaginal delivery. Augmentation means  enhancing  uterine
contractions once labour has started. For successful induction, cervical
ripening is important.
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Physiology of cervical ripening:
Progressive increase in gestation or vaginal infection
Increase in cervical hyaluronidase & decreased collagenase inhibitors.
Down regulation of estrogen & progesterone receptors.
Increased Interleukin 8 & Interleukin 1 β stimulates collagenase &
neutrophilic chemotaxis and enzymatic degradation of extracellular matrix
Increased water content
Decreased collagen concentration & structural rearrangement
Alteration of proteoglycans & glycosaminoglycans ratio
26
CERVICAL RIPENING
INDICATION FOR INDUCTION OF LABOUR
Maternal indications:
 Abruptio placenta
 PROM
 Chorioamnionitis
 Post term
 PIH, pre eclampsia, eclampsia
 Maternal conditions like diabetes, renal disorder, chronic
hypertension
Fetal indications:
 Fetal demise
 Fetal malformation incompatiable with life
 Fetal jeopardy like IUGR
CONTRAINDICATIONS FOR INDUCTION OF LABOUR
Absolute:
 Severe CPD
 Placenta previa III&IV
 Transverse lie
 Previous classical caesarean or myomectomy
 Active genital herpes infection
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 Invasive cervical carcinoma
 Pelvic structural deformities.
Relative;
 Grand multipara
 Previous LSCS
 Multiple pregnancy
 Breech
 Polyhydramnios
 Presenting part above inlet
 Maternal heart disease
Pre requisites for induction:
 Establish the indication
 Informed consent
 Pelvic assessment
 Confirmation of gestational age
 Assessment of fetal size & presentation
 Cervical assessment ( modified Bishop score)
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BISHOP SCORE – In 1964 E.H. Bishop suggested a qualitative pelvic
scoring based on 500 pelvic examinations for success of induction.
Factors 0 1 2 3
Cervical Dilatation (cm) Closed 1-2 3-4 5+
Effacement of cervix (%) 0-30 40-50 60-70 80+
Consistency of cervix Firm Medium Soft
Position of cervix Posterior Mid line Anterior
Head station -3 -2 -1,0 +1,+2
Unfavorable score <6
Favorable score >6
METHODS OF INDUCTION
 Natural methods
 Mechanical methods
 Pharmacological methods
Natural methods:
 Nipple stimulation
 Sexual intercourse
 Enema
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Mechanical methods:
 Stripping of membranes
 Balloon catheters
 Laminaria tents
 Synthetic osmotic dilators
 Amniotomy also known as surgical induction, used for induction
&augmentation.
Pharmacological method : Drugs commonly used are:
o Oxytocin
o Prostaglandins
OXYTOCIN
Oxytocin is secreted by the posterior pituitary along with ADH.
It  is  an octapeptide  and it simulates natural labour. Its  half  life is  2-
7 minutes. It is rapidly degraded in the liver & kidney by oxytocinase.
Oxytocin binds to oxytocin receptors & increases calcium release from
endoplasmic reticulum which increases production of prostaglandin from
decidua to bring about uterine contractions. Oxytocin is responsible for
labour contractions through estrogen sensitized receptors and milk
ejection reflex for lactation. Oxytocin was the first polypeptide hormone
synthesized in 1953 by Du Vigneaud.
30
Mode of administration:
Oxytocin is administered as an infusion via infusion pump or by
manual counting in isotonic electrolyte solution .A Steady state plasma
levels is achieved by 30-40 minutes.
Uses:
 Induction of labour
 Uterine inertia
 Oxytocin challenge test
 Postpartum haemorrhage
Dosage protocols for induction:
Regimen Starting Increment Interval Max
(mU/min) Dose (mU/min) dose(mu/min) Mins Dose(mU/min)
Low dose 0.5-1 1 30-40 20
1-2 2 15 40
High dose 6 6,3,1 15-40 42
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Side effects :
 Hyper stimulation –In high dose protocol
 Failed induction
 Uterine rupture
 Hypotension –IV bolus
 Water intoxication
 Neonatal hyper bilirubinemia
RCOG GUIDELINES:
1.Oxytocin should be started 4-6 hours following prostaglandins
2.In women with intact membrane, do an amniotomy & then start oxytocin
3.Minimum possible dose should be used & titrated against uterine
contractions.
4. Maximum licensed dose is 20mU/min & should not exceed 32mU/min.
PROSTAGLANDINS :
First described by Von Euler and is believed to originate  from
prostate and seminal vesicle.
They are biologically active derivatives of 20 carbon atom poly
unsaturated essential fatty acids that are synthesised from the cell
membrane. Prostaglandins are derivatives of prostanoic acid. They are
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metabolized in  the liver and  excreted  through the kidneys. Prostaglandins
have varied actions depending upon the tissue and type of prostaglandin.
The probable mechanism of action is alteration of membrane bound Ca++
by inhibiting adenyl cyclase and decreasing the level of intracellular cyclic
AMP.
The physiological roles of prostaglandins in female reproductive
tract are Ovulation, Sperm transport, Luteolysis, Menstruation, Labour.
Modes of administration:
 Intra muscular
 Intravenous (not used now)
 Oral
 Vaginal
 Rectal
 Sublingual
Uses :
 Medical abortion
 Cervical ripening before surgical abortion
 Induction of labour in second trimester
 Cervical priming and induction of labour in third trimester
 In prevention and treatment of post partum haemorrhage
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Other Uses :
 Peptic ulcer
 To maintain patency of ductus arteriosus
 In glaucoma as second line of drugs
Contraindications :
Absolute :
 Hypersensitivity
 Asthma
 Uterine scar
Relative
 Hypertension
 CVS disease
 Renal disease
 Liver disease
 Glaucoma
Side effects :
 Fever
 Nausea, vomiting and diarrhoea
 Bronchospasm
 Uterine hyperstimulation
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Commonly used prostaglandins are Prostaglandin E1 (Misoprostol) ,
Prostaglandin E2 (Cerviprime gel) , Prostaglandin F2 Alpha
CERVIPRIME GEL :
- It is a prostaglandin E2 analogue
- Local application of cerviprime gel used for cervical ripening
(ACOG)
- It can be used both intra vaginally and intra cervically.
- Available as 0.5 mg gel.
- Most effective when vaginal pH > 4.5
- Requires refrigeration
- Application should be done in or near the labour ward where
uterine activity and fetal heart rate monitoring can be performed.
- Contraction occurs within first 4 hours of application and shows peak
activity in the first 4 hours.
- If oxytocin was used for acceleration, it should be started after 6 – 12 hrs
of the after application.
ACOG recommendations for induction of labour:
Level A : (based on good& consistent scientific evidence)
- Prostaglandin E2 (PGE2) analogues are effective agents for
cervical ripening & labour induction.
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-Fetal heart rate & uterine activity should be continuously
monitored from the time PGE2 vaginal insertion.
- High dose PGE2 vaginal suppository may be used in 2nd trimester
fetal demise.
- Misoprostol 25μg every 3-6 hrs is effective for cervical ripening &
labour induction.
- With PROM, induction may be done with prostaglandins.
- Either low/high dose oxytocin regime may be used for induction.
Level B (based on limited/ inconsistent scientific evidence)
- Use of misoprostol is to be avoided in women with previous LSCS
- Higher doses of misoprostol are associated with increased risk of
uterine hyperstimulation.
Level C (Based on Upon consensus & expert opinion)
- Intravaginal misoprostol for induction of labour in 3rd trimester with
fetal demise
-FHR & uterine activity should be monitored from 30 min to 2hours after
prostaglandin administration in live fetus.
36
MATERIALSANDMETHODS
Period of study :
September 2017 to August 2018
Materials and methods :
A total of 100 women with premature of rupture of membrane
(PROM) admitted in labour ward Govt.Tirunelveli medical college hospital
were recruited for the study. A detailed history was obtained and a clinical
examination and obstetric examination was done. A speculum examination
and a vaginal examination was performed. Gestational age was
calculated   using Naegle’s rule and confirmed clinically and by ultrasound.
The ripeness of cervix was assessed using modified Bishop’s score.
Inclusion criteria ;
1. Primi/ multigravida
2. >37 wks of gestation
3. Cephalic presentation
4. Singleton pregnancy
5. Bishop’s score < 6
6. No cephalopelvic disproportion
7. Reassuring CTG
37
Exclusion criteria :
1. Multiple pregnancy
2. Contraindication to vaginal birth
3. Previous uterine surgery
4. Contraindication to prostaglandins
5. Non reassuring CTG
6. Chorioamnionitis
7. Active labour
8. Preterm premature rupture of membranes
After admission vital parameters like pulse, B.P, temperature was
recorded.
All patients underwent an obstetric  examination to clinically confirm
the gestational age, the lie of the foetus, presentation and the amount of
liquor. A speculum examination and vaginal examination was done to
confirm the leakage of liquor, colour of liquor, the ripeness of cervix, the
presentation and to rule out CPD.
An USG was done in all patients to assess the amount of liquor,
placental position, gestational age. CTG was done in all patients.
Before starting on drugs, informed consent was obtained. All the patients
were given intravenous antibiotics.
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50 patients belonging to group A had PGE2 gel 0.5mg instilled
into the endocervical canal. After 6 hours cervical score was assessed. If still
unripe a second  dose was  instilled. If the cervical score was favourable
(score >6) , labour was augumented with 5 units  of oxytocin drip,
which was titrated to achieve effective uterine contractions.
50 patients belonging to group B were started on i.v oxytocin drip
5units in 500 ml of Ringer lactate. The drip rate was titrated to achieve
effective uterine contractions.
In both the groups, labour progress was monitored using a partogram.
The parameters monitored were :
Maternal pulse rate, B.P, temperature, Cervical dilatation, station of
head, foetal heart rate, drugs given.
If any signs of foetal distress were noted, the patients were taken up
for caesarean section. Maternal and foetal outcome and complications
were analysed .
Statistical Tools
The information collected regarding all the selected cases were
recorded in a Master Chart. Data analysis was done with the help of
computer using Epidemiological Information Package (EPI 2002).
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Using this software, frequencies, percentage, mean, standard
deviation, x2 and 'p' values were calculated. A 'p' value less than 0.05 is
taken to denote significant relationship.
OBSERVATION
Out of 100, 50 were given cerviprime gel intracervical
instillation, 50 were given iv oxytocin.
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RESULTS
Table 1: Age Distribution
Age in years
Cerviprime Gel
group
Oxytocin group
No % No %
< 20 - - 4 8
20 – 24 20 40 29 58
25 – 29 29 58 15 30
30 & above 1 2 2 4
Total 50 100 50 100
Mean 24.9 23.96
S.D 2.79 3.51
‘p’ 0.1808 (Not significant)
0%
40%
58%
2%
Cerviprime Gel group
< 20
20 – 24
25 – 29
30 & above
41
8%
58%
30%
4%
Oxytocin group
< 20
20 – 24
25 – 29
30 & above
< 20 20 – 24 25 – 29 30 & above
0
20
29
1
4
29
15
2
Cerviprime Gel group Oxytocin group
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40% (20/50) of group A and 58% (29/50) of group B were in the age
group of 20 to 24 years.
58%(29/50) of group A and 30%(15/50) of group B were in the age
group of 25 to 29 years.
0% in group A and 8% (4/50) of group B were in the age group of <
20 years.
2%(1/50) of group A and 4%(2/50) of group B were in the age
group of  > 30 years.
There is no statistically significant difference between two groups.
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Table 2 : Parity
Parity Cerviprime Gel group Oxytocin group
No % No %
Primi 30 60 33 66
Multi 20 40 17 34
Total 50 100 50 100
’p’ 0.7382 (Not Significant)
Primi
60%
Multi
40%
Cerviprime Gel group
Primi
Multi
44
Primi
66%
Multi
34%
Oxytocin group
Primi
Multi
0
5
10
15
20
25
30
35
Primi Multi
Cerviprime Gel group Oxytocin group
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60%(30/50) of group A and 66% (33/50) of group B were prim
gravidas .
40%(20/50) of group A   and 33%(17/50) of group B were
multigravidas.
There is no statistically significant difference between two
groups.
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Table 3 : PROM to induction interval
PROM to
induction interval
in minutes
Cerviprime Gel group Oxytocin group
No % No %
< 120 16 32 12 24
121 – 240 27 54 27 54
241 – 360 6 12 11 22
> 360 1 2 - -
Total 50 100 50 100
Mean 175.8 176.3
S.D 80.05 77.9
‘p’ 0.7717 (Not Significant)
32%
54%
12% 2%
Cerviprime Gel group
< 120
121 – 240
241 – 360
> 360
47
24%
54%
22% 0%
Oxytocin group
< 120
121 – 240
241 – 360
> 360
0
5
10
15
20
25
30
< 120 121 – 240 241 – 360 > 360
Cerviprime Gel group Oxytocin group
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The duration of PROM to induction was <2hours in 32% (16/50)
of group A and 24% (12/50) of group B .
The duration of PROM to induction was between 2 to 4hours in
54% (27/50) of both groups.
The duration of PROM to induction was 4 to 6 hours in 12% (6/50)
of group A and 22%(11/50) of group B.
The duration of PROM to induction was > 6 hours in 2% (1/ 50) of
group A and 0% in group B.
There is no statistically significant difference between two groups.
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Table 4 : Bishop Score
Bishop Score Cerviprime Gel group Oxytocin group
No % No %
3 25 50 10 20
4 19 38 33 66
5 6 12 7 14
6 - - - -
50%
38%
12% 0%
Cerviprime Gel group
Bishop Score 3
Bishop Score 4
Bishop Score 5
Bishop Score 6
50
20%
66%
14% 0%
Oxytocin group
Bishop Score 3
Bishop Score 4
Bishop Score 5
Bishop Score 6
0
5
10
15
20
25
30
35
Bishop Score 3 Bishop Score 4 Bishop Score 5 Bishop Score 6
Cerviprime Gel group Oxytocin group
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The Bishop’s score was 3 in 50 %(25/50) of group A and 20%
(10/50) of group  B.
The Bishop’s score was 4 in 38% (19/50) of group  A and
66%(33/50) of group B.
The Bishop’s score was 5 in 12%(6/50) of group A and 14%
(7/50) of group B.
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Table 5 : PROM to Delivery interval
PROM to
Delivery interval
( in minutes)
Cerviprime Gel group Oxytocin group
‘p’
Mean SD Mean SD
Primi 602.3 118.9 682.4 91.7 0.0104
(Significant)
Multi 539.5 119.8 655 102.6 0.0048
(Significant)
Total 577.2 122 673.1 95.4 0.0002
(Significant)
The mean duration of PROM to delivery in primigravidas were 602.3
minutes in group A and 682.4 minutes in group B.
The mean duration of PROM to delivery in multigravidas were
539.5minutes in group A and 655 minutes in group B.
‘p’ value was significant in both groups. PROM to delivery interval
was faster in both primigrvida and multigravida with gel induction
compared to syntocinon infusion.
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Table 6 : Induction to Delivery interval
Induction to delivery
interval (in minutes)
Cerviprime Gel
group
Oxytocin group
‘p’
Mean SD Mean SD
Primi 430.5 114.9 507.6 75.5 0.0034
(Significant)
Multi 357.8 99.3 475.9 69.3 0.0004
(Significant)
Total 401.4 113.7 496.8 74.3 0.0001
(Significant)
The mean duration of induction to delivery in primigravidas were
430.5 minutes in  group A  and 507.6minutes in  group B.
The mean duration of induction to delivery in multigravidas
were 357.8 in group A and 475.9 in group B.
‘p’ value (0.0001) was significant in both groups. Induction  to
delivery interval was faster in both primigrvida and multigravida with gel
induction compared to syntocinon infusion.
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SECOND GEL REQUIRED :
6% of the patient in cerviprime gel group required second gel which
was kept after 6 hours of first gel induction. The efficacy of single dose gel
was 94%.
Oxytocin acceleration in cerviprime gel induction group
16% of the patients in cerviprime gel group required oxytocin for
acceleration of labour.
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Table 7 : Mode of Delivery
Mode of delivery Cerviprime Gel groupOxytocin group
No % No %
a) Vaginal 47 94 48 96
i) Labour natural 40 80 40 80
ii) Outlet 7 14 8 16
b) Caesarean 3 6 2 4
Labour Natural Outlet forceps
40
7
40
8
VAGINAL DELIVERY
Cerviprime Gel group Oxytocin group
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Vaginal Caesarean
47
3
48
2
MODE OF DELIVERY
Cerviprime Gel group Oxytocin group
6%
80%
14%
94%
Cerviprime Gel group
Caesarean Labour natural Outlet
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In group A 80 %(40/50) were delivered by labour naturale,14%(7/50)
were delivered by outlet forceps,6%(3/50) were delivered by caesarean
section for non reassuring fetal heart rate with thick meconium.
In group B 80%(40/50) were delivered by labour naturale,14% (7/50) were
delivered by outlet forceps. 1 patient was delivered by low midcavity
forceps. 4%(2/50) of patients were taken up for LSCS foetal distress.
94% of patients were delivered with first dose of cerviprime gel induction.
of which 16%   required oxytocin for   acceleration. Both instrumental
and caesarean section rate were same in both groups.
4%
80%
16%
96%
Oxytocin group
Caesarean Labour natural Outlet
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Table 8 : Apgar score at 1” and 5”
Apgar score
at
Cerviprime Gel group Oxytocin group
No % No %
1 minute
6 / 10
7 / 10
8 / 10
9 / 10
2
31
17
0
4
62
34
0
4
33
13
0
8
66
26
0
‘p’ 0.4305
Not significant5 minutes
6 / 10
7 / 10
8 / 10
9 / 10
0
2
31
17
0
4
62
34
0
3
34
13
0
6
68
26
‘p’ 0.3534
Not significant
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6/10 7/10 8/10 9/10
0 2
31
17
0
3
34
13
APGAR SCORE AT 5 MIN
Cerviprime Gel group Oxytocin group
6/10 7/10 8/10 9/10
2
31
17
0
4
33
13
0
APGAR SCORE AT 1 MIN
Cerviprime Gel group Oxytocin group
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Apgar score at 1 minute was 6/10 in 4%(2/50) of group A and
8%(4/50) of group B babies.
Apgar score at 1 minute was 7/10 in 62%(31/50) of group A and
66%(33/50) of group B babies.
Apgar score at 1 minute was 8/10 in 34%(17/50) of group A and
26%(13/50) of group B babies.
‘p’ value was not significant in both groups.
Apgar score at 5 minutes was 7/10 in 4%(2/50) of group A and
6%(3/50) of group B babies.Apgar score at 5minutes was 8/10 in 62%
(31/50) of group A and 68%(34/50) of group B babies.
Apgar score at 5 minutes was9/10 in 34% (17/50) of group A and
26%(13/50) of group B babies.
‘p’ value was not significant in both groups
61
Table 9 : Complications
Complications Cerviprime group Oxytocin group
No % No %
a) Intra Partum
Fetal distress
No Fetal distress
6
44
12
88
4
46
8
92
‘p’ 0.7389
Not significant
b) Post partum
PPH
No PPH
2
48
4
96
3
47
6
94
‘p’ 0.5
Not Significant
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12% (6/50) of patients in group A and 8%(4/50) of patients in
group B were developed foetal distress.
None of the patients developed chorio amnionitis.
None of the patients developed hyper stimulation.
4%(2/50) of patients in group A and 6%(3/50)of patients
in group B developed atonic PPH, which was managed medically.
0
5
10
15
20
25
30
35
40
45
50
Fetal distress No Fetal distress PPH No PPH
Complications
Cerviprime group Oxytocin group
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Table 10 : Neonatal Outcome
Neonatal
Outcome
Cerviprime Gel groupOxytocin group
No % No %
Admission HIE 1 5 10 5 10
Admission MAS 0 0 3 6
Not admitted 45 90 42 84
Antibiotic received 0 0 0 0
‘p’ 0.552 (Not Significant)
Cerviprime Gel group
Admission HIE 1 Admission MAS Not admitted Antibiotic received
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10%(5/50) of newborn in group A and 16%(8/50)of newborn in
group B were admitted in neonatal intensive care unit were treated with
antibiotics.
Oxytocin group
Admission HIE 1 Admission MAS Not admitted Antibiotic received
0
5
10
15
20
25
30
35
40
45
Admission HIE 1 Admission MAS Not admitted Antibiotic received
Chart Title
Cerviprime Gel group Oxytocin group
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90%(45/50) of newborn in group A and 84%(42/50) of  newborn
in group B had normal Apgar scores and didn’t require admission in
neonatal intensive care unit.
10% (5/50) in group A and 10% (5/50) in group B were admitted in
neonatal intensive care unit for Hypoxic ischemic encephalopathy.
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Table 11 : Stay in hospital
Stay in hospital
(in days)
Cerviprime Gel group Oxytocin group
No % No %
3 days 40 80 41 82
4 days 7 14 6 12
More than 5
days
3 6 3 6
Mean 3.44 3.36
S.D 1.21 1.05
‘p’ 0.8007
Not Significant
3 days 4 days More than 5 days
40
7
3
41
6
3
STAY IN HOSPITAL
Cerviprime Gel group Oxytocin group
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80% (40/50) of patients in group A and 82%(41/50) of patients in
group B were discharged on 3rd day.
14%(7/50) of patients in group A and 12% (3/50) of patients in
group B were discharged on 4th day.
80%
14%
6%
Cerviprime Gel group
3 days
4 days
More than 5 days
82%
12%
6%
Oxytocin group
3 days
4 days
More than 5 days
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6% (3/50) of patients in group A and 4%(2/50) of patients in
group B were discharged on 8th day.
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DISCUSSION
Prelabour rupture of membranes is a common indication for induction
of labour.   Clinical management of PROM at term remains controversial.
Many investigators  believe that prolonged the interval from PROM to
delivery is associated with  increased  incidence of maternal and perinatal
infections.
Induction  of labour with prostaglandins offers the advantage of
promoting  both cervical ripening  and  myometrial contractility  in  the
group of women who present with premature rupture of membrane and
an unfavourable cervix.
Common prostaglandins used are PGE1, PGE2. Misopostol is
associated with more hyperstimulation and fetal distress. PGE2 induces
labour effectively in patients with unfavourable cervix.
Intravenous oxytocin in PROMwith unfavorable cervix takes a longer
time for induction to delivery. In this study, of 100 patients for induction of
labour in term PROM, 50 patients were given iv oxytocin infusion and 50
patients were given PGE2 cerviprime gel endocervically.
1.  Age :
In our study, the mean age of the cases in cerviprime gel group was
24.9 years and oxytoin group was 23.96 years. In a study conducted by
Chaudhuri Snehamay et al, the mean age in cerviprime gel group was
23.2 years and oxytocin group was 23.9 years.
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2.  Parity :
In our study, 63% were primi gravidas, 37% were multigravidas. In
the study conducted by Chaudhuri Snehamay et al,     75% were primi
gravidas. The study conducted by Kodkany and Telang et al also had greater
number of primigravidas.
3.  Duration of PROM to induction :
In our study, the duration of PROM to induction was between 2-4
hours in 54% of the cases in both groups.   This is in par with the study
conducted by Hauth et al which reported duration of PROM to induction
was 3 hrs in 59%.
4.  Bishop’s Score
In the study conducted by Chaudhuri Snehamay et al, the Bishop’s
score was < 6 in 67.5% of cases in cerviprime gel group and 69.6% in
oxytocin group. In our study, the Bishop’s score was < 6 in all patients in
both groups.
5.  Duration of PROM to delivery :
The duration of PROM to delivery in gel group was 10 hrs for
primi, 8.9 hrs for multi gravida, the mean was 9.5 hrs. In oxytocin group
PROM to delivery interval was 11.3 hrs in primi, 10.9 hrs in multi, mean
was 11.1 hrs which was also statistically significant. The mean latency
between the PROM and delivery in the study conducted by Gonen et al, was
15 hr with PGE2 gel, Chaudhuri Snehamay et al, was 17 hrs.   In Gonen
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et al study, they have reported the duration of PROM to delivery to be 30
hrs, with the use of iv oxytocin for induction. But Chauduri Snehamay et al
study, oxytocin was started after 12-24 hrs of PROM. The PROM to
delivery interval was 21 hrs.
6.  Induction to Delivery interval :
In cerviprime gel group, the mean time from induction to delivery
was 7.1 hrs in primi, 5.9 hrs in multi with mean duration of 6.6 hrs. In
syntocinon group it was 8.4 hrs in primi, 7.9 hrs in multi, with mean duration
of 8.2 hrs. they were statistically significant.
The results were comparable with study conducting by Gonen et al
(1992). The mean interval between the PG2 gel application and delivery was
6.6 hrs in their study. Another study conducted by Chaudhuri Snehamay et
al the mean duration of induction to delivery with PGE2 gel was 8.5 hrs.
In our study in the cerviprime gel group, 94% delivered in a single
application. Of which, 16% required oxytocin for acceleration. This was
similar to the study conducted by Gonen et al, who reported that 93%
delivered after a single application of PGE2 gel. In Chaudhuri Snehamay et
al study, they have reported 91.8% success rate.   Ben Haroush et al
reported 80% success rate with induction by vaginal instruction of PGE2
tablet.
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7. Mode of Delivery :
The rate of cesarean section in our study was 6% for cerviprime gel
group and 4% for oxytocin group.     A randomized control study
conducted by Hannah et al they found there is no significant difference in
the rate of ceasarean section. The study of induction with oxytocin or
prostaglandin for planned management of PROM by Dare et al, reported
that there was no significant difference in the mode of delivery.
8.  Apgar score :
Apgar score at 1 min was less than 7/10 in 4% of the cases in group
A, compared to 8% in oxytocin group. This is comparable with the study
conducted by Chaudhury Snehamay et al, which reported the Apgar score at
1 minute to be less than 7 in 5.4% of cases in gel group Vs 7.1 % in oxytocin
group. None of the babies in either group had Apgar score less than 7/10 at
5 minutes in our study and the study conducted by Chaudhury Snehamay
et al. Apgar score at 1 min and 5 min was not statistically significant in
the Herabutya et al study. In our study also statistically significant difference
was not noted in Apgar score at 1 min and 5 min. Also there was no
significant difference in the incidence of fetal distress in both groups.
9. Perinatal outcome :
In Gonen et al study, there was no adverse perinatal outcome. The
perinatal outcome was not significant in our study.
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10.  Maternal Complications :
Severe maternal complications  like chorioamnionitis and post
partum endometritis was not observed in both groups in our study.
Chaudhury Snehamay et al, reported post partum fever in 1.8% of cases
in gel group and 0.8% in oxytocin group.
11. Duration of stay in hospital :
The duration of stay in hospital was not statistically significant in both
groups.
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SUMMARY
This study evaluated the efficacy of PGE2 cerviprime gel for
induction of labour in premature rupture of membranes with intravenous
oxytocin.
1. 58% of the patients in group A and 30% of the patients in group B
belonged to age group of 25-29 years.
2. 60% of the patients in group A and 66% of the patients in group B
were primigravidas. 40% of the patients in Group A and 34% of the
patients in Group B were multigravida.
3. Premature rupture of membrane to induction in the interval was 2
to 4 hrs in 54% of the cases in both groups.
4. The Bishop’s score was less than 6 in all cases in both groups.
5. The mean PROM to delivery interval was 9.5 hrs, with PGE2 gel,
11.1 hrs with oxytocin which was statistically significant. (p =
0.0002).
6. The mean induction to delivery interval was 6.6 hrs with PGE2 gel,
8.2 hrs with oxytocin which was statistically significant.
(p=0.0001). 6% of the cases in ceviprime gel group required a second
gel after 6 hrs of induction and 16% of the cases in the same group
required oxytocin for acceleration of labour.
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7. 94% in the gel group and 96% in oxytocin group delivered
vaginally. 6% in the gel group and 4% in the oxytocin group delivered
by caesarean section.
8. 1 minute Apgar score was more than 7/10 in 96% of cases in
group A and 92% of cases in group B. 5 minute Apgar score was
more than 7/10 in all cases in both groups.
9. Fetal distress in gel group was 12% compared to 8% in oxytocin
group.
10. 4% of cases in gel group and 6% of cases in oxytocin group had
post partum haemorrhage. None of the patients developed
chorioamnionitis or hyperstimulation in either groups.
11. 10% of the babies in cerviprime gel group were admitted in NICU
for hypoxic ischemic encephalopathy stage I. 10% of the babies in
oxytocin group were admitted in NICU for hypoxic ischemic
encephalopathy stage I and 6% for meconium aspiration syndrome
12. 80% of the cases in both groups were discharged from hospital after
3 days.
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CONCLUSION
1. Prostaglandin E2 gel was more effective and safer in induction of
labour, in cases with  premature rupture of membranes compared to
intravenous oxytocin infusion.
2. Use of PGE2 Gel  for induction of labour in premature rupture of
membrane significantly reduced the induction to delivery interval
compared to intravenous oxytocin.
3. There was no significant difference in the mode of delivery between both
groups.
4. There was no significant difference in the neonatal outcome and
immediate puerperal problems between both groups.
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PROFORMA
1. Name:
2. Age :
3. IP no :
4. Obstetric code:
5. Gestational age: LMP: EDD:
6. Ultrasound:
7. Date and time of admission:
8. Date and time of rupture of membranes:
9. Method of confirming rupture of membranes:
A) Pooling of liquor on speculum examination
B) Absent membranes
C) Reduced liquor on USG
10. Bishop’s score:
11. Date and time of induction :
12. Method of induction :
a) PGE2 gel b)oxytocin
Repeat gel
Oxytocin for augmentation
13. Date and time of delivery :
14. Mode of delivery :
o labour naturale
o operative vaginal
o caesarean
15. Duration of PROM :
16. Duration of induction to delivery :
17. Duration of PROM to delivery :
18. Intrapartum complications:
i) Hyperstimulation
ii) Foetal distress
iii) Chorioamnionitis
iv) PPH
19. Neonatal outcome
1. Apgar 1minute
5minutes
2. Resuscitation with oxygen
3. Admission in NICU
4. Neonatal infection
5. Neonatal death
20. Duration of stay in hospital
NehahspfSf;F mwptpg;G kw;Wk; xg;Gjy; gbtk; 
(kUj;Jt Ma;tpy; gq;Nfw;gj;w;F) 
Ma;T nra;ag;gLk; jiyg;G:  
gq;F ngWthpd; ngaH: 
gq;F ngWthpd; taJ: 
  gq;F ngWth; 
,jid  
Fwpf;fTk; 
1.  ehd; NkNy Fwpg;gpl;Ls;s kUj;Jt Ma;tpd; tptuq;fis gbj;J 
Ghpe;J nfhz;Nld;. vd;Dila re;Njfq;fis Nfl;fTk;> 
mjw;fhd jFe;j tpsf;fq;fis ngwTk; tha;g;gspf;fg;gl;Ls;sJ 
vd mwpe;J nfhz;Nld;. 
 
2.  ehd; ,t;tha;tpy; jd;dpr;irahf jhd; gq;Nfw;fpNwd;. ve;j 
fhuzj;jpdhNyh ve;j fl;lj;jpYk;> ve;j rl;l rpf;fYf;Fk; 
cl;glhky; ehd; ,t;tha;tpy; ,Ue;J tpyfp nfhs;syhk; vd;Wk; 
mwpe;J nfhz;Nld;. 
 
3.  ,e;j Ma;T rk;ge;jkhfNth> ,ij rhHe;J NkYk; Ma;T 
Nkw;fhs;Sk; NghJk; ,e;j Ma;tpy; gq;FngWk; kUj;JtH 
vd;Dila kUj;Jt mwpf;iffis ghHg;gjw;F vd; mDkjp 
Njitapy;iy vd mwpe;J nfhs;fpNwd;. ehd; Ma;tpy; ,Ue;J 
tpyfpf; nfhz;lhYk; ,J nghUe;Jk;; vd mwpfpNwd;. 
 
4.  ,e;j Ma;tpd; %yk; fpilf;Fk; jftiyNah> KbitNah 
gad;gLj;jpf; nfhs;s kWf;f khl;Nld;. 
 
5.  ,e;j Ma;tpy; gq;F nfhs;s xg;Gf; nfhs;fpNwd; vdf;F 
nfhLf;fg;gl;lmwpTiufspd; gb ele;J nfhs;tJld;> Ma;it 
Nkw;nfhs;Sk; kUj;Jt mzpf;F cz;ikAld; ,Ug;Ngd; vd;W 
cWjpaspf;fpNwd;. vd; cly; eyk; ghjpf;fg;gl;lhNyh> my;yJ 
vjpHghuhj> tof;fj;jpw;F khwhd Neha;Fwp njd;gl;lhNyh clNd 
,ij kUj;Jt mzpaplk; njhptpg;Ngd; vd cWjp mspf;Nwd;. 
 
 
gq;Nfw;gthpd; ifnahg;gk; / .................................................... ,lk; ........................................... 
fl;iltpuy; Nuif 
gq;Nfw;gthpd; ngaH kw;Wk; tpyhrk; ........................................................................................ 
Ma;thshpd; ifnahg;gk; /...................................................... ,lk; ............................................ 
Ma;thshpd; ngaH ......................................................................................................................... 
ikak; ...............................................................................................................................................  
fy;tpawpT ,y;yhjtw;F (ifNuif itj;jtHfSf;F) ,J mtrpak; Njit 
rhl;rpapd; ifnahg;gk; /...................................................... ,lk; ................................................ 
ngaH kw;Wk; tpyhrk; ................. ................................................................................................... 
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1 31283 GEL 23 1 38 C 3 420 660 240 No No - 7 8 - - 3
2 31207 GEL 29 2 37 C 4 360 740 380 No No - 8 9 - - 3
3 33508 GEL 23 1 38 C 4 285 685 400 No No - 7 8 - - 3
4 31297 GEL 27 1 38 C 5 310 570 260 No No - 8 9 - - 3
5 33021 GEL 27 2 38 C 4 120 520 400 No No - 8 9 - - 3
6 33824 GEL 24 1 37 C 3 80 540 460 No No - 8 9 - - 3
7 46611 GEL 21 2 38 C 3 135 675 540 No YES FetalDistress 7 8 Admission HIE I - 8
8 475190 GEL 20 1 38 C 3 180 525 345 No No - 7 8 - - 3
9 48199 GEL 28 2 38 C 4 110 570 460 No No - 7 8 - - 3
10 42744 GEL 26 2 38 C 3 150 485 335 No No - 8 9 - - 3
11 46599 GEL 21 1 37 C 4 150 615 465 No No - 8 9 - - 3
12 44548 GEL 29 2 38 C 3 180 630 450 No No - 7 8 - - 4
13 43546 GEL 21 2 38 C 5 90 375 285 No No - 8 9 - - 3
14 42590 GEL 26 1 37 C 3 150 695 545 No No - 7 8 - - 3
15 45133 GEL 26 1 37 C 3 210 885 675 No YES FetalDistress 6 8 Admission HIE I - 8
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16 44536 GEL 29 1 37 C 4 120 490 370 No No - 8 9 - - 3
17 48205 GEL 22 1 38 C 4 210 750 540 YES No - 7 8 - - 4
18 48470 GEL 26 2 38 C 3 105 490 385 No No - 7 8 - - 3
19 44810 GEL 20 1 37 C 4 210 685 475 No No - 8 9 - - 3
20 46290 GEL 26 1 37 C 4 210 690 480 No No - 7 8 - - 3
21 48640 GEL 22 1 38 C 3 120 665 545 No No - 7 8 - - 3
22 48592 GEL 20 1 38 C 3 89 460 371 No No - 7 8 - - 3
23 54210 GEL 22 2 37 C 3 170 485 315 No No - 8 9 - - 3
24 48581 GEL 24 1 38 C 4 140 645 505 No No - 7 8 - - 3
25 48153 GEL 24 2 38 C 5 150 465 315 No No - 7 8 - PPH 3
26 48205 GEL 22 1 38 C 5 70 520 450 No No - 7 8 - - 3
27 52942 GEL 27 2 38 C 4 120 510 390 No No - 8 9 - - 3
28 53508 GEL 22 1 37 C 4 210 720 510 YES No FetalDistress 6 8 - - 4
29 51524 GEL 22 1 38 C 3 185 640 455 No No - 7 8 - - 3
30 51070 GEL 26 1 37 C 3 75 490 415 No No - 7 8 - - 3
31 51084 GEL 26 1 38 C 3 210 620 410 No YES - 7 8 - - 4
32 50725 GEL 26 1 37 C 4 185 610 425 No YES - 7 8 - - 3
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33 50804 GEL 27 2 37 C 3 180 680 500 No YES FetalDistress 7 7 Admission HIE I - 4
34 53504 GEL 22 2 38 C 3 210 660 450 No YES - 7 8 - - 3
35 51334 GEL 26 1 38 C 4 135 520 385 No No - 7 8 - - 3
36 53818 GEL 28 2 38 C 4 60 385 325 No No - 8 9 - - 3
37 55842 GEL 28 2 38 C 4 95 405 310 No No - 7 8 - PPH 3
38 55333 GEL 26 1 37 C 3 160 835 675 YES No FetalDistress 7 7 Admission HIE I - 8
39 52017 GEL 26 1 38 C 4 110 665 555 No YES - 7 8 - - 3
40 55345 GEL 25 1 38 C 5 210 610 400 No No - 8 9 - - 3
41 54410 GEL 21 1 38 C 3 185 410 225 No No - 8 9 - - 3
42 54390 GEL 26 2 39 C 4 240 400 160 No No - 8 9 - - 3
43 55342 GEL 28 2 38 C 5 195 465 270 No No - 7 8 - - 3
44 59669 GEL 25 1 38 C 3 150 390 240 No No - 7 8 - - 3
45 60180 GEL 25 1 38 C 3 90 470 380 No No - 7 8 - - 4
46 61240 GEL 22 1 38 C 3 120 560 440 No No FetalDistress 7 8 Admission HIE I - 4
47 62797 GEL 28 2 38 C 3 360 765 405 No YES - 8 9 - - 3
48 61263 GEL 28 1 38 C 3 175 448 273 No No - 7 8 - - 3
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49 61280 GEL 30 2 37 C 4 310 470 160 No No - 7 8 - - 3
50 62780 GEL 27 2 37 C 3 295 615 320 No No - 8 9 - - 3
51 42575 SYN 22 1 38 C 4 110 630 520 - - - 8 9 - - 3
52 44606 SYN 22 1 37 C 4 140 680 540 - - FetalDistress 7 8 Admission MAS - 4
53 43787 SYN 23 1 38 C 3 160 670 510 - - - 7 8 - - 3
54 43517 SYN 20 2 37 C 5 120 590 470 - - - 7 8 - - 3
55 44584 SYN 23 2 37 C 4 300 695 395 - - - 7 8 - - 3
56 47907 SYN 29 1 38 C 4 180 675 495 - - - 7 8 - - 3
57 41576 SYN 30 2 37 C 5 35 525 490 - - - 8 9 - - 3
58 48508 SYN 19 1 38 C 4 180 655 475 - - - 7 8 Admission HIEI - 4
59 48850 SYN 20 1 37 C 4 150 675 525 - - - 7 8 - - 3
60 47029 SYN 19 2 38 C 5 150 575 425 - - - 8 9 - - 3
61 48818 SYN 30 2 38 C 4 160 595 435 - - - 8 9 - - 3
62 48518 SYN 24 1 39 C 4 100 790 690 - - - 7 8 - PPH 4
63 48586 SYN 20 1 38 C 4 150 735 585 - - FetalDistress 6 8 Admission MAS - 4
64 49501 SYN 29 2 37 C 3 80 600 520 - - - 8 9 - - 3
65 49769 SYN 20 1 38 C 4 160 630 470 - - - 7 8 Admission HIE I - 4
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66 50145 SYN 29 1 37 C 4 260 710 450 - - - 8 9 - - 3
67 50183 SYN 24 2 37 C 5 150 620 470 - - - 8 9 - - 3
68 54995 SYN 28 2 37 C 4 360 810 450 - - - 7 8 - - 3
69 50550 SYN 22 1 38 C 4 330 925 595 - - - 7 8 - - 3
70 50223 SYN 23 2 38 C 4 120 580 460 - - - 7 8 - - 3
71 50577 SYN 22 1 38 C 4 190 670 480 - - - 8 9 - - 3
72 50710 SYN 23 1 38 C 4 150 645 495 - - - 7 8 - - 3
73 51356 SYN 29 1 38 C 3 120 665 545 - - - 7 8 - - 3
74 50297 SYN 23 1 39 C 5 180 720 540 - - - 7 8 - - 3
75 50245 SYN 24 2 38 C 5 140 555 415 - - - 7 8 - - 3
76 52670 SYN 29 1 38 C 4 255 650 395 - - FetalDistress 6 7 Admission MAS - 8
77 50518 SYN 29 1 39 C 4 70 550 480 - - - 8 9 - - 3
78 50539 SYN 19 1 37 C 4 190 630 440 - - - 8 9 - - 3
79 51829 SYN 18 1 38 C 5 150 600 450 - - - 7 8 - - 3
80 52061 SYN 23 1 37 C 4 225 685 460 - - - 7 8 - - 4
81 52278 SYN 23 2 37 C 4 300 840 540 - - - 7 8 - - 3
82 52078 SYN 29 1 39 C 4 210 590 380 - - - 8 9 - - 3
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83 52386 SYN 23 2 38 C 4 280 700 420 - - - 7 8 - - 3
84 52084 SYN 21 1 38 C 3 210 655 445 - - - 7 7 Admission HIE I PPH 5
85 52284 SYN 23 1 38 C 4 170 635 465 - - FetalDistress 6 7 Admission HIE I - 8
86 53256 SYN 25 1 38 C 3 135 645 510 - - - 7 8 - - 3
87 53497 SYN 22 1 38 C 4 180 780 600 - - - 7 8 - - 3
88 53290 SYN 22 2 38 C 3 180 810 630 - - - 8 9 - - 3
89 53225 SYN 21 1 38 C 4 275 650 375 - - - 7 8 - - 3
90 53540 SYN 28 2 38 C 3 150 780 630 - - - 7 8 - - 3
91 53844 SYN 29 1 38 C 3 210 615 405 - - - 8 9 Admission HIE I - 3
92 53523 SYN 29 2 38 C 4 50 530 480 - - - 7 8 - - 3
93 54210 SYN 22 1 38 C 4 110 615 505 - - - 7 8 - - 3
94 55951 SYN 28 2 37 C 4 255 675 420 - - - 7 8 - - 3
95 54360 SYN 25 1 38 C 3 30 600 570 - - - 7 8 - - 3
96 54332 SYN 22 1 38 C 4 270 810 540 - - - 7 8 - - 3
97 53970 SYN 23 1 37 C 3 330 1000 670 - - - 6 8 - PPH 3
98 54436 SYN 21 1 38 C 4 140 675 535 - - - 7 8 - - 3
99 54890 SYN 21 1 38 C 4 50 660 610 - - - 7 8 - - 3
100 54321 SYN 26 2 38 C 4 215 655 440 - - - 7 8 - - 3
